Sand Grove Capital Management’s Acceleron Pharma XLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,668
Closed -$133K 19
2021
Q3
$133K Buy
+1,668
New +$218K 0.02% 12